Citizens cuts Rocket Lab stock price target on Neutron delay to 2027
Citizens lowered its price target for Rocket Lab USA (RKLB) to $90 from $130, citing a delay in the Neutron launch vehicle's first flight to 2027 due to manufacturing defects. The company discovered air bubbles in the first-stage tank, requiring a redesign. Other analysts have also adjusted targets but maintained positive ratings. RKLB stock is down 21% year-to-date, underperforming the S&P Aerospace & Defense ETF and the Russell 3000.
How this was made
The 30-second read
Why it matters
The news is a primary disclosure of a program delay and analyst target reduction, likely prompting short‑term sell pressure.
Market read
The delay and target cut are fresh, material news for RKLB, suggesting downside risk in the near term.
What to watch
Potential upside from successful future Neutron launch and continued support from other analysts.
Background
Rocket Lab announced a delay of its Neutron rocket to 2027 after discovering air bubbles in a first‑stage tank, prompting analysts to cut price targets.
Ticker impact
Citizens lowered Rocket Lab's price target to $90 and noted the Neutron launch delay to 2027 due to tank defects.
likely pressure as the market prices in the launch postponement and lower target.
Analyst downgrade and a significant program delay are fresh, material news for a small-cap aerospace firm.
Market effects
May weigh on aerospace & defense sector sentiment as launch schedule uncertainty rises.
Limited to U.S. small-cap investors; no broad regional effect.
Minimal global impact beyond niche space launch market.
Counterpoint
Some investors may view the delay as a temporary setback and maintain bullish exposure to Rocket Lab's long-term growth.
Key entities
- companyRocket Lab USA
Space launch provider whose Neutron vehicle launch is delayed.
- analystCitizens
Research firm that lowered the price target to $90.
